The American Urological Association (AUA) recently updated its guidelines on commonly used surgical procedures and minimally invasive surgical treatments. Following is the group's latest advice on which to consider—and which to avoid.
Some men who take medication for benign prostatic hyperplasia (BPH) that belongs to a class of drugs known as 5-alpha reductase inhibitors (5-ARIs) have reported developing depression and suicidal thoughts, but this risk appears to be small.
If a man with an enlarged prostate has symptoms that seem unmanageable with lifestyle measures alone, what's the next step?
Watchful waiting is the best option for some men with an enlarged prostate. Are you a candidate?
If you take a dietary supplement for benign prostatic hyperplasia (BPH), you may be getting more—or less—than you bargained for.
It's almost a given that as men age, they develop prostate enlargement and are increasingly plagued by a frequent need to urinate. The condition can be a real hassle, so much so that men will try almost anything to relieve it.
A variety of medical options are available to treat BPH, but if your symptoms are mild, they may be manageable with the practical measures.
Transurethral resection of the prostate (TURP) is the most common surgical treatment for benign prostatic enlargement (BPE), but a newer technique may appeal to men who want to avoid certain side effects.
Known as simple prostatectomy, surgery for benign prostatic hyperplasia (BPH), typically involves removing only the prostate tissue that is surrounding and pressing on the urethra.
Why some men develop benign prostatic hyperplasia (BPH) and others don’t remains unclear. Recently, however, one intriguing hypothesis—based on a modest, but growing body of research—has emerged.